Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

China · Delayed Price · Currency is CNY

6.96

+0.06 (0.87%)

Jul 3, 2026, 3:00 PM CST

-31.02% (1Y)

Market Cap	7.27B -25.7%
Revenue (ttm)	5.71B -6.5%
Net Income	86.96M -78.6%
EPS	0.09 -80.3%
Shares Out	1.05B
PE Ratio	78.74
Forward PE	n/a
Dividend	0.05 (0.72%)
Ex-Dividend Date	n/a

Volume	26,809,446
Open	6.98
Previous Close	6.90
Day's Range	6.81 - 7.02
52-Week Range	6.48 - 11.30
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:600789

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its products to European Union, the United States, the United Kingdom, Russia, India, Brazil, Japan, and internationally. The company was formerly known as Jini... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1966

Employees 6,469

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600789

Full Company Profile

Financial Performance

In 2025, SHA:600789's revenue was 5.77 billion, a decrease of -7.49% compared to the previous year's 6.23 billion. Earnings were 112.30 million, a decrease of -71.54%.

Financial Statements